Fake Doctor Absconding After 12-Year-Old Dies Following IV Infusion in Thane
A 12-year-old boy from Diva, Thane, died after allegedly receiving intravenous medicines administered by a bogus doctor at his residence. According to officials, the incident began on May 26, when the family of Devendra Ashish Singh sought additional treatment after his fever failed to improve despite care at a government hospital in Dombivli. The accused, identified as Shishir Roy, allegedly dismissed the earlier prescription and administered medications through a saline drip at home.
Seizures During Infusion, Death Days Later
Authorities stated that during the second IV infusion, the child reportedly developed seizures and was rushed to a private hospital before being transferred to KEM Hospital. He subsequently died on June 1. An inquiry by the Thane Municipal Corporation (TMC) found that the accused allegedly lacked recognised medical qualifications, did not possess a registered clinic, and was practising without legal authorization. A joint raid by health officials and the FDA reportedly led to the seizure of medicines, injections, and medical supplies from the premises where he was treating patients.
- Delhi Health Procurement Scam: ACB Arrests Former CPA Chief Dr Vinod Kumar Ranga
- Mumbai Crime Branch Arrests EduVio Directors in Alleged NEET MBBS Admission Scam
- NEET UG 2026 Re-Exam: No Leave for Medical Students on June 20-21 Ahead of Retest
Crackdown Reveals Wider Public Health Concern
The accused is currently absconding, and a case has been registered under provisions of the Maharashtra Medical Practitioners Act and the Bharatiya Nyaya Sanhita. The case has also highlighted the continuing threat posed by unqualified practitioners in vulnerable communities. TMC officials revealed that a city-wide verification drive covering 1,481 practitioners identified 24 suspected bogus doctors, with six under priority investigation and FIRs already filed against three individuals. More than 40% of the suspected cases were reportedly concentrated in Diva, Mumbra, and Shilphata areas, raising concerns about healthcare access, regulation, and patient safety.
